What can be termed a medical breakthrough, the researchers at the Tata Memorial Center of Mumbai have developed a new, affordable cancer treatment that can prevent cancer from recurring. The promising new cancer treatment is in the form of a ₹100 prooxidant tablet containing resveratrol and copper (R+Cu). This tablet targets a potential cause of cancer recurrence: cell fragments, cell-free chromatin particles (cfChPs), released by dying cancer cells that can trigger cancer in healthy cells. Containing resveratrol and copper, R+Cu generates oxygen radicals in the stomach that enter the bloodstream and destroy these cfChPs.
In pre-clinical trials on rats, R+Cu showed a 50 percent reduction in chemotherapy and radiation side effects. While early results suggest a 30 percent effectiveness in preventing cancer recurrence, human trials for prevention are still needed. This breakthrough offers hope for improved cancer treatment affordability and reduced patient burden. The tablet awaits approval from India’s food safety agency and could be available for human clinical trials by June-July 2024 if successful.
EXAMINING THE RESEARCH
Denne historien er fra April 2024-utgaven av Healthcare Radius.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra April 2024-utgaven av Healthcare Radius.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
Dengue-related searches surge on Justdial
Justdial data reveals significant increase in dengue-related searches and pest control services this monsoon season, amid severe dengue outbreak in India.
Ipca launches NovaLead's Diulcus for diabetic foot ulcer
Ipca Laboratories launches NovaLead's patented drug Diulcus, for the treatment of diabetic foot ulcer in India.
Sahyadri Hospitals unveils advanced radiotherapy treatment
Sahyadri Hospitals launches Asia's first advanced radiotherapy treatment, Radixact X9 system with Vital Hold technology for precise cancer treatment.
Complex liver transplant saves diabetic patient
Wockhardt Hospitals, Mumbai Central and South Asian Liver Institute provide liver transplant services to a Botswanian patient.
Gynecological cancers rise in young Indian women
Experts stress need for awareness, early screening, and advanced treatment options like robotic-assisted surgery for gynecological cancers.
Mahajan Imaging, Siemens unveil AI diagnostic analyzer
Mahajan Imaging and Labs and Siemens Healthineers launch India's first Al-diagnostic analyzer.
Nimotuzumab boosts head and neck cancer survival - Tata Memorial study
A Tata Memorial study finds Nimotuzumab increases 10-year survival rate for head and neck cancer patients.
Kolkata doctor rape and murder: Everything you wanted to know
Protesting doctors demand better workplace safety and stricter policy measures.
AYUSH treatments to be covered under PM-JAY?
Very soon, AYUSH treatments may be covered under AB PM-JAY.
WHAT DOCTORS MUST TELL PATIENTS ABOUT DRY EYE SYNDROME
Dry eye syndrome affects lakhs of people globally, causing discomfort and vision issues. Learn how doctors must guide patients about managing it.